We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is a Beat in the Cards for CME Group (CME) in Q2 Earnings?
Read MoreHide Full Article
CME Group Inc. (CME - Free Report) is slated to report second-quarter 2024 earnings on Jul 24, before market open. CME's earnings beat estimates in each of the trailing four quarters.
Factors to Consider
A diverse product portfolio, increased volatility, as well as a strong market position are likely to have aided CME Group’s performance in the second quarter.
Increases in market data and information services, clearing, transaction fees and other revenues are likely to have aided CME’s top line in the to-be-reported quarter. The Zacks Consensus Estimate for revenues is pegged at $1.53 billion, indicating a rise of 12.2% from the year-ago reported figure.
Clearing and transaction fees are likely to have benefited from higher Energy and Agriculture trading volumes and cash markets business. We expect clearing and transaction fees to be $1.2 billion, indicating a 6.7% increase from the year-ago reported figure.
Market data and information services revenues are likely to have gained from price increases for certain products, a rise in device counts, higher custody fees as well as improvements in co-location and other connectivity fees. We expect the figure to be $164.7 million, indicating a 1% increase from the year-ago reported figure.
Expenses are likely to have increased in the to-be-reported quarter due to higher compensation and benefits, technology and amortization of purchased intangibles. We anticipate expenses to be $477.7 million in the to-be-reported quarter.
The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $2.53, indicating an increase of 10% from the year-ago quarter’s reported figure.
What the Zacks Model Says
Our proven model predicts an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold).
Earnings ESP: CME Group has an Earnings ESP of +0.16%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: CME Group currently carries a Zacks Rank of 3.
Other Stocks to Consider
Here are some other stocks from the finance sector that have the perfect mix of elements to beat on earnings in their upcoming quarterly releases.
Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +2.10% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $2.08 per share, indicating a year-over-year increase of 16.8%. You can see the complete list of today’s Zacks #1 Rank stocks here.
CBOE’s earnings beat estimates in each of the last four quarters.
Intercontinental Exchange Inc. (ICE - Free Report) has an Earnings ESP of +0.67% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $1.48 per share, indicating a year-over-year increase of 3.5%.
ICE’s earnings beat estimates in each of the last four quarters.
Nasdaq, Inc. (NDAQ - Free Report) has an Earnings ESP of +0.85% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at 64 cents per share, indicating a year-over-year decrease of 9.8%.
NDAQ’s earnings beat estimates in three of the last four quarters and missed once.
Image: Bigstock
Is a Beat in the Cards for CME Group (CME) in Q2 Earnings?
CME Group Inc. (CME - Free Report) is slated to report second-quarter 2024 earnings on Jul 24, before market open. CME's earnings beat estimates in each of the trailing four quarters.
Factors to Consider
A diverse product portfolio, increased volatility, as well as a strong market position are likely to have aided CME Group’s performance in the second quarter.
Increases in market data and information services, clearing, transaction fees and other revenues are likely to have aided CME’s top line in the to-be-reported quarter. The Zacks Consensus Estimate for revenues is pegged at $1.53 billion, indicating a rise of 12.2% from the year-ago reported figure.
Clearing and transaction fees are likely to have benefited from higher Energy and Agriculture trading volumes and cash markets business. We expect clearing and transaction fees to be $1.2 billion, indicating a 6.7% increase from the year-ago reported figure.
Market data and information services revenues are likely to have gained from price increases for certain products, a rise in device counts, higher custody fees as well as improvements in co-location and other connectivity fees. We expect the figure to be $164.7 million, indicating a 1% increase from the year-ago reported figure.
Expenses are likely to have increased in the to-be-reported quarter due to higher compensation and benefits, technology and amortization of purchased intangibles. We anticipate expenses to be $477.7 million in the to-be-reported quarter.
The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $2.53, indicating an increase of 10% from the year-ago quarter’s reported figure.
What the Zacks Model Says
Our proven model predicts an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold).
Earnings ESP: CME Group has an Earnings ESP of +0.16%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
CME Group Inc. Price and EPS Surprise
CME Group Inc. price-eps-surprise | CME Group Inc. Quote
Zacks Rank: CME Group currently carries a Zacks Rank of 3.
Other Stocks to Consider
Here are some other stocks from the finance sector that have the perfect mix of elements to beat on earnings in their upcoming quarterly releases.
Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +2.10% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $2.08 per share, indicating a year-over-year increase of 16.8%. You can see the complete list of today’s Zacks #1 Rank stocks here.
CBOE’s earnings beat estimates in each of the last four quarters.
Intercontinental Exchange Inc. (ICE - Free Report) has an Earnings ESP of +0.67% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at $1.48 per share, indicating a year-over-year increase of 3.5%.
ICE’s earnings beat estimates in each of the last four quarters.
Nasdaq, Inc. (NDAQ - Free Report) has an Earnings ESP of +0.85% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2024 earnings is pegged at 64 cents per share, indicating a year-over-year decrease of 9.8%.
NDAQ’s earnings beat estimates in three of the last four quarters and missed once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.